Farrell Peter C insider trades
Farrell Peter C has filed 43 Form 4s with the SEC that we hold, for Resmed INC (RMD) (Director), Arcturus Therapeutics Holdings Inc. (ARCT) (Director) and Evolus, Inc. (EOLS) (Director). Across all of them we count 1 purchase worth $91.0K and 22 sales worth $17.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 8 sales ($5.0M). The largest single trade was a sale of 12,600 shares of Resmed INC worth $3.0M, dated 2023-05-03. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-17 and the latest 2026-09-04.
Resmed INC (RMD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-10-31 | S, sale reported on Form 4 | 9,050 | $2.0M | 2022-11-02 |
| 2023-05-03 | S, sale reported on Form 4 | 12,600 | $3.0M | 2024-02-23 |
| 2024-02-22 | S, sale reported on Form 4 | 10,935 | $2.0M | 2024-02-23 |
| 2024-09-04 | S, sale reported on Form 4 | 2,000 | $479.8K | 2024-09-06 |
| 2024-10-02 | S, sale reported on Form 4 | 2,000 | $474.4K | 2024-10-02 |
| 2024-11-06 | S, sale reported on Form 4 | 2,000 | $497.5K | 2024-11-08 |
| 2024-12-04 | S, sale reported on Form 4 | 2,000 | $491.3K | 2024-12-05 |
| 2025-01-02 | S, sale reported on Form 4 | 2,000 | $462.0K | 2025-01-03 |
| 2025-02-05 | S, sale reported on Form 4 | 2,000 | $484.2K | 2025-02-05 |
| 2025-03-05 | S, sale reported on Form 4 | 2,000 | $455.4K | 2025-03-06 |
| 2025-04-02 | S, sale reported on Form 4 | 2,000 | $439.5K | 2025-04-04 |
| 2025-05-07 | S, sale reported on Form 4 | 2,000 | $484.5K | 2025-05-08 |
| 2025-06-04 | S, sale reported on Form 4 | 2,000 | $494.6K | 2025-06-06 |
| 2025-07-02 | S, sale reported on Form 4 | 945 | $241.4K | 2025-07-03 |
| 2025-11-12 | S, sale reported on Form 4 | 2,000 | $504.1K | 2025-11-13 |
| 2025-12-03 | S, sale reported on Form 4 | 2,000 | $502.9K | 2025-12-04 |
| 2026-01-07 | S, sale reported on Form 4 | 2,000 | $497.7K | 2026-01-09 |
| 2026-02-04 | S, sale reported on Form 4 | 2,000 | $502.6K | 2026-02-06 |
| 2026-03-04 | S, sale reported on Form 4 | 2,000 | $520.4K | 2026-03-05 |
| 2026-04-01 | S, sale reported on Form 4 | 2,000 | $450.0K | 2026-04-02 |
| 2026-08-05 | S, sale reported on Form 4 | 8,000 | $1.8M | 2026-08-06 |
| 2026-09-02 | S, sale reported on Form 4 | 970 | $227.7K | 2026-09-04 |
Arcturus Therapeutics Holdings Inc. (ARCT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Evolus, Inc. (EOLS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-09-06 | P, purchase reported on Form 4 | 10,000 | $91.0K | 2022-09-06 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1186102) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms